Firefly Neuroscience announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024. Dr. Vnook will serve as Chairperson of the Nominating Committee. Vnook is the CEO of Likarda Biotech, a drug-delivery biotechnology specializing in advanced cell therapy solutions, as well as the Founder and Chair of OralBiolife Biosciences, a biotechnology company specializing in re-mineralization and re-growth of the bone starting with the treatment of periodontal disease.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AIFF:
- Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors
- Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11
- Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th
- Firefly Neuroscience formed strategic partnership with NCD
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders